|
|
Volumn 67, Issue 3, 2016, Pages 343-344
|
|
CHA2DS2-VASc score for predicting stroke and thromboembolism in patients with AF and biological valve prosthesis
a
a
a
a
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICOAGULANT AGENT;
ANTIVITAMIN K;
ANTICOAGULATION;
AORTA VALVE PROSTHESIS;
ATRIAL FIBRILLATION;
CARDIOVASCULAR DISEASE ASSESSMENT;
CEREBROVASCULAR ACCIDENT;
CHA2DS2 VASC SCORE;
FEMALE;
FOLLOW UP;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL DEVICE COMPLICATION;
MITRAL VALVE PROSTHESIS;
PRACTICE GUIDELINE;
PREDICTION;
PRIORITY JOURNAL;
PROGNOSIS;
PROSTHETIC VALVE THROMBOSIS;
RISK ASSESSMENT;
TREATMENT OUTCOME;
ADVERSE EFFECTS;
BIOPROSTHESIS;
COMPLICATION;
DEVICES;
HEART VALVE DISEASES;
HEART VALVE PROSTHESIS;
HEART VALVE REPLACEMENT;
METHODOLOGY;
POSTOPERATIVE COMPLICATIONS;
PROCEDURES;
STATISTICAL MODEL;
STROKE;
ATRIAL FIBRILLATION;
BIOPROSTHESIS;
HEART VALVE DISEASES;
HEART VALVE PROSTHESIS;
HEART VALVE PROSTHESIS IMPLANTATION;
HUMANS;
MODELS, STATISTICAL;
POSTOPERATIVE COMPLICATIONS;
PROGNOSIS;
RESEARCH DESIGN;
RISK ASSESSMENT;
STROKE;
|
|
EID: 84957812514
PISSN: 07351097
EISSN: 15583597
Source Type: Journal
DOI: 10.1016/j.jacc.2015.10.061 Document Type: Letter |
|
Times cited : (8)
|
|
References (4)
|
